|

VEN (Venetoclax) Clinical Trials

2 actively recruiting trials

Also known as: Azacitidine

Pipeline

Phase 2: 2

Top Sponsors

  • Yehui Tan1
  • The First Affiliated Hospital of Soochow University1

Indications

  • Cancer2
  • Adult T-cell Leukemia/Lymphoma1
  • Transplantation1
  • Myelodysplastic Neoplasms1

Other2 trials

Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
Phase 2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.